SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-063385
Filing Date
2018-12-06
Accepted
2018-12-06 16:30:21
Documents
3
Period of Report
2018-12-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv508617_8k.htm 8-K 18449
2 EXHIBIT 99.1 tv508617_ex99-1.htm EX-99.1 20643
3 GRAPHIC image_001.jpg GRAPHIC 4439
  Complete submission text file 0001144204-18-063385.txt   46563
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 181221024
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1